Delivery Order SPE2DB22D3102-SPE2DB25FK9KV

Award Date 1/6/25
Potential Completion Date 1/7/25
Potential Value $3.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB24D2010|SPE2DB25FZSX8, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of the pharmaceutical product TRELEGY ELLIPTA 100-62.5-25 60S. It is a firm fixed-price delivery order contract with a ceiling value of $11,209.90 and an ultimate completion date of November 25, 2024. The contract does not have a set-aside designation, indicating an open competition....
This federal contract award, with the ID SPE2DB20D3111|SPE2DB25FA6MP, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, and has a ceiling value of $7,869.95. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is January 30, 2025. Amerisourcebergen Drug Corp is a major pharmaceutical distributor...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB25FDST5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $31,281.77. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 3, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug...
This federal contract award, with ID SPE2DX15D3110|SPE2DX23F22FS, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract provides for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $3,888.82. This is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is May 12, 2023. The contract does not have a set-aside...
This federal contract award, with ID SPE2DB22D3301|SPE2DB24FY7TX, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract, valued at $3,430.37, is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product. The contract has a firm fixed price and an ultimate completion date of June 3, 2024. This contract award is not designated with a set-aside requirement. Amerisourcebergen Drug Corp, a major pharmaceutical...
This federal contract award, with ID SPE2DB22D3301|SPE2DB25FX6HN, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a medical product, with a ceiling value of $1,461.18. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FHR59, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $6,908.31. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of June 11, 2024. This award is not designated as a set-aside contract. Amerisourcebergen Drug...
This federal contract award, with an ID of SPE2DB22D2005|SPE2DB25FJGW6, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $28,472.23 and a completion date of January 31, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by...
The federal contract award, valued at $27,961.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the provision of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a completion date of January 7, 2025. The contract has a Firm Fixed Price pricing type and is not designated as a set-aside. Amerisourcebergen holds a significant Indefinite...
This federal contract award, with the ID SPE2DB20D1109|SPE2DB24FN13F, was issued by the Defense Logistics Agency (DLA) to the prime contractor AmerisourceBergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a ceiling value of $6,131.17 and a completion date of November 24, 2023. The contract is a Delivery Order under a Firm Fixed Price pricing type. This award is not designated as a set-aside contract. AmerisourceBergen Drug Corp...
  • SPE2DB22D3102
    Indefinite Delivery Contract
  • SPE2DB22D3102-SPE2DB25FK9KV
    Delivery Order

This federal contract award, with ID SPE2DB22D3102|SPE2DB25FK9KV, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with an ultimate completion date of January 7, 2025 and a ceiling value of $3,650.21. The contract is a Delivery Order under a Firm Fixed Price pricing type. There was no set-aside used for this award. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies, particularly within military and veterans' healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 4/7/25, 10:45 AM